A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging

Neurology

Volumn 48, Issue 6, 1997, Pages 1517-1521

  Kawas, Claudia ^a,d   Resnick, S ^b   Morrison, A ^a   Brookmeyer, R ^c   Corrada, M ^a   Zonderman, A ^b   Bacal, C ^b   Donnell Lingle, D ^b   Metter, E ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; DEMENTIA; DEMOGRAPHY; DIAGNOSTIC IMAGING; DRUG USE; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; NEUROLOGIC EXAMINATION; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; STATISTICAL ANALYSIS; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030748719     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1517     Document Type: Article

References (50)

1. Katzman R, Aronson M, Fuld P, et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324.
2. Bachman DL, Wolf PA, Linn R, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 1992;42:115-119.
3. Folstein MF, Basset SS, Anthony JC, Romanoski AJ, Nestadt GR. Dementia: case ascertainment in a community survey. J Gerontol 1991;46:132-138.
4. Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990;10:1286-1291.
5. Toran-Allerand CD, Miranda RC, Bentham WD, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992;89:4668-4672.
6. Brenner DE, Kukull WA, Stergachis A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 1994;140:262-267.
7. Graves AB, White E, Koepsell TD, et al. A case-control study of Alzheimer's disease. Ann Neurol 1990;28:766-774.
8. Broe GA, Henderson AS, Creasey H, et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990;40: 1698-1707.
9. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and non-demented control subjects. Arch Neurol 1994;51:896-900.
10. Mortel KF, Meyer JS. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 1995;7:334-337.
11. Tang M, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
12. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease. Am J Epidemiol 1994;140:256-261.
13. Paganini-Hill A, Henderson V. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med 1996;156: 2213-2217.
14. Martyn CN, Pippard EC. Usefulness of mortality data in determining the geography and time trends of dementia. J Epidemiol Comm Health 1988;42:134-137.
15. Shock N, Greulich R, Andres R, et al. Normal human aging: the Baltimore Longitudinal Study of Aging. Washington, DC: US Government Printing Office, 1984 [NIH Publication No. 84-2450].
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association, 1987.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
18. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34:187-220.
19. SAS Institute Inc. The PHREG Procedure. In: Anonymous-SAS/STAT software: changes and enhancements, release 6.10. Cary, NC: SAS Institute Inc., 1994:83-113.
20. Breitner JC, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-232.
21. Lucca U, Tettamanti M, Forloni G, Spagnoli A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol Psychiatry 1994;36:854-856.
22. Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MMB, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk of Alzheimer's disease? Neurology 1995;45:1441-1445.
23. Stewart W, Kawas C, Corrada M, Metter E. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48: 626-632.
24. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementiaAlzheimer's type. Psychoneuroendocrinology 1986;11:337-345.
25. Asthana S, Craft S, Baker L, et al. Transdermal estrogen improves memory in women with Alzheimer disease [abstract]. Soc Neurol 1996;22:200.
26. Honjo H, Tanaka K, Kashiwagi T, et al. Senile dementia-Alzheimer's type and estrogen. Horm Metab Res 1995;27:204-207.
27. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer's type: 7 case reports. Dementia 1995;6:99-107.
28. Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996;46: 1580-1584.
29. Sherwin BB. Estrogenic effects on memory in women. In: Luine VN, Harding CF, eds. Hormonal restructuring of the adult brain: basic and clinical perspectives. New York: The New York Academy of Sciences, 1994:213-229.
30. Hackman BW, Galbraith D. Replacement therapy and piperazine oestrone sulphate ("Harmogen") and its effect on memory. Curr Med Res Opin 1976;4:303-306.
31. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977;4:31-47.
32. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994;42:919-922.
33. Rauramo L, Lagerspetz K, Engblom P, Punnonen R. The effect of castration and peroral estrogen therapy on some psychological functions. Front Horm Res 1975;3:94-104.
34. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269:2637-2641.
35. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-357.
36. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
37. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994;83: 979-983.
38. Hampson E, Kimura D. Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav Neurosci 1988;102:456-459.
39. Hampson E. Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn 1990;14:26-43.
40. Hampson E. Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology 1990;15:97-111.
41. Phillips SM, Sherwin BB. Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 1992;17:497-506.
42. Niki E, Nakano M. Estrogens as antioxidants. Methods Enzymol 1990;186:330-333.
43. Smalheiser NR, Swanson DR. Linking estrogen to Alzheimer's disease: an informatics approach. Neurology 1996;47:809-810.
44. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer's Disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-1239.
45. Etienne P, Robitaille Y, Wood P, Gauthier S, Nair NPV, Quirion R. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 1986;19:1279-1291.
46. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985;89:484-490.
47. Honjo H, Tamura T, Matsumoto Y, et al. Estrogen as a growth factor to central nervous cells. Estrogen treatment promotes development of acetylcholinesterase-positive basal forebrain neurons transplanted in the anterior eye chamber. J Steroid Biochem Mol Biol 1992;41:633-635.
48. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 1994;14:7680-7687.
49. Namba H, Sokoloff L. Acute administration of high doses of estrogen increases glucose utilization throughout brain. Brain Res 1984;291:391-394.
50. Murphy DG, DeCarli C, Daly E, et al. X-chromosome effects on female brain: a magnetic resonance imaging study of Turner's syndrome. Lancet 1993;342:1197-1200.